Lawsuits Over the Price of Insulin-State Efforts for Insulin Access

Daniel G. Aaron,I. Glenn Cohen,Eli Y. Adashi

JAMA INTERNAL MEDICINE（2024）

引用 0|浏览0

暂无评分

摘要

This Viewpoint discusses the litigation strategy of state-initiated lawsuits alleging illegal and immoral conduct regarding the pricing of insulin by pharmaceutical companies and pharmacy benefit managers.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要